Secai Raises $6.2M Series A to Expand Healthcare Automation
Montreal-based health AI company Secai has closed a $6.2 million Series A financing round. The funds will support the commercial expansion of its Voxira solution and enhance engineering and product capabilities.
Montreal, Canada – February 11, 2026— Montreal-based health AI company Secai announced today the closing of a $6.2 million Series A financing round. The investment will support the commercial expansion of its Voxira solution, strengthen engineering and product capabilities, and accelerate adoption across Canada and the United States.
Secai has reported significant market traction, supporting clinics across North America, and became the first voice AI certified by the Quebec Ministry of Health in August 2025. The company states that healthcare systems in North America continue to face a critical shortage of clinical administrative staff, creating access challenges and operational strain. Secai's AI infrastructure addresses this gap by automating patient communications, appointment workflows, documentation, and care coordination.
Investors viewed healthcare as being at a pivotal moment where AI can meaningfully improve both operational efficiency and patient outcomes. Secai's strong clinical foundation, combined with early adoption by leading health systems, demonstrated a differentiated and credible approach to deploying AI in real-world healthcare environments.
The Series A funding will be used to expand Voxira and NoteGen nationwide, deepen integrations with major EMR platforms, and advance research and development in clinical reasoning and agentic workflows. Secai aims to build what it describes as the operating system of the modern clinic.